Dose Splitting During GLP-1 Shortage: Is It Safe
Pharmaceutical availability gaps are still affecting users across all 50 states. Here’s up-to-date tracking on stock status and options.
Supply Snapshot
Based on the latest data, supply conditions for semaglutide and tirzepatide products varies significantly by:
- Drug and dose: Lower starter doses are often more available than maintenance doses
- Where you live: Distribution networks favor high-volume markets while less populated regions face more difficulty
- Where you fill: Mail-order options may stock what chain pharmacies can’t get
Dose-Specific Tracking
Initial Titration Strengths
Starter doses are generally easier to find because:
- Fewer patients stays at starting strength indefinitely
- Manufacturers focus production on these strengths to guarantee new patient access
Higher Dosing
Target dosing experience worse shortages because:
- The majority of users accumulate at higher doses and continue long-term
- Output can’t keep up as more patients titrate up
What to Do
Right Now
- Call ahead — never drive to a pharmacy without calling availability
- Try multiple locations — contact multiple pharmacies including independent ones
- Request to be called — some locations will call upon receiving a shipment
Extended Supply Issues
- Contact your doctor about alternative dosing — your prescriber could suggest an alternative approach
- Ask about 503B pharmacy products — if the drug is officially in shortage, compounded alternatives can be prescribed
- Check manufacturer assistance — pharma companies offer resources to help patients find supply
Monitoring Resources
Check these sources to track availability:
- FDA.gov shortage page — the most reliable data
- Manufacturer websites — production news published by the manufacturers
- CVS/Walgreens/Walmart apps — may display whether it’s in stock
- Patient communities — other patients post current where they found it
This page is updated when new information becomes available.